Rodin Therapeutics
Alkermes snaps up Rodin Therapeutics for a potential $950 million
November 19, 2019Manufacturing and Production, Sales and Marketing Alkermes, Rodin Therapeutics, pharma
Dublin’s Alkermes is set to acquire US firm Rodin Therapeutics in a deal worth a potential $950 million, it has …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
